Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$6.1 - $10.41 $5,624 - $9,598
-922 Reduced 7.14%
11,988 $83,000
Q1 2024

Apr 22, 2024

BUY
$7.77 - $10.61 $12,688 - $17,326
1,633 Added 14.48%
12,910 $136,000
Q4 2023

Jan 16, 2024

BUY
$6.53 - $8.23 $4,727 - $5,958
724 Added 6.86%
11,277 $90,000
Q3 2023

Oct 24, 2023

SELL
$7.69 - $9.71 $1,661 - $2,097
-216 Reduced 2.01%
10,553 $86,000
Q2 2023

Jul 25, 2023

BUY
$5.72 - $8.8 $1,344 - $2,068
235 Added 2.23%
10,769 $86,000
Q1 2023

Apr 14, 2023

SELL
$6.28 - $9.85 $13,633 - $21,384
-2,171 Reduced 17.09%
10,534 $85,000
Q4 2022

Feb 08, 2023

SELL
$6.09 - $7.93 $26,619 - $34,662
-4,371 Reduced 25.6%
12,705 $79,000
Q3 2022

Oct 25, 2022

SELL
$4.58 - $9.21 $59,961 - $120,577
-13,092 Reduced 43.4%
17,076 $118,000
Q2 2022

Aug 12, 2022

BUY
$7.06 - $23.63 $21,215 - $71,008
3,005 Added 11.06%
30,168 $252,000
Q1 2022

May 11, 2022

SELL
$21.6 - $27.79 $829,656 - $1.07 Million
-38,410 Reduced 58.58%
27,163 $621,000
Q4 2021

Feb 08, 2022

BUY
$23.0 - $29.01 $1.03 Million - $1.3 Million
44,901 Added 217.21%
65,573 $1.81 Million
Q3 2021

Nov 02, 2021

BUY
$25.04 - $30.06 $19,906 - $23,897
795 Added 4.0%
20,672 $576,000
Q2 2021

Aug 11, 2021

SELL
$27.43 - $32.7 $41,419 - $49,377
-1,510 Reduced 7.06%
19,877 $583,000
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $40,047 - $64,428
-1,874 Reduced 8.06%
21,387 $679,000
Q4 2020

Feb 12, 2021

SELL
$15.31 - $21.12 $63,873 - $88,112
-4,172 Reduced 15.21%
23,261 $482,000
Q3 2020

Nov 04, 2020

BUY
$14.88 - $20.13 $7,395 - $10,004
497 Added 1.85%
27,433 $426,000
Q2 2020

Jul 17, 2020

BUY
$13.31 - $20.51 $72,725 - $112,066
5,464 Added 25.45%
26,936 $493,000
Q1 2020

Apr 21, 2020

BUY
$12.98 - $30.25 $26,816 - $62,496
2,066 Added 10.65%
21,472 $333,000
Q4 2019

Feb 12, 2020

SELL
$18.89 - $31.89 $17,227 - $29,083
-912 Reduced 4.49%
19,406 $581,000
Q3 2019

Nov 07, 2019

SELL
$20.88 - $25.66 $57,774 - $71,001
-2,767 Reduced 11.99%
20,318 $443,000
Q2 2019

Aug 06, 2019

BUY
$20.52 - $26.45 $86,779 - $111,857
4,229 Added 22.43%
23,085 $581,000
Q1 2019

May 06, 2019

SELL
$20.23 - $26.29 $234,668 - $304,964
-11,600 Reduced 38.09%
18,856 $466,000
Q4 2018

Feb 11, 2019

SELL
$17.64 - $28.32 $70,295 - $112,855
-3,985 Reduced 11.57%
30,456 $563,000
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $710,862 - $884,100
34,441 New
34,441 $884,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.